文献速递腹部泌尿生殖MR

治疗前MRI显示侧方淋巴结转移对接受新辅助放化疗后根治性手术但未行侧方淋巴结清扫的直肠癌患者的预后价值:系统综述与Meta分析

Prognostic value of lateral lymph node metastasis in pretreatment MRI for rectal cancer in patients undergoing neoadjuvant chemoradiation followed by surgical resection without lateral lymph node dissection: A systemic review and meta-analysis.
PubMed 文献 · Eur J Radiol · 2024-07-02

该系统综述与Meta分析纳入9项研究共3180例接受新辅助放化疗后根治性手术但未行侧方淋巴结清扫的直肠癌患者,评估治疗前MRI显示侧方淋巴结转移与预后的关联。结果显示侧方淋巴结转移与局部复发率升高(HR 4.11)、无病生存期缩短(HR 1.70)和总生存期缩短(HR 1.76)显著相关,远处转移风险呈升高趋势但未达统计学显著(HR 1.67,95%CI 0.85–3.27)。

要点

  • 治疗前MRI显示侧方淋巴结转移者局部复发风险升高(HR 4.11,95%CI 1.87–9.02)。
  • 侧方淋巴结转移与无病生存期(HR 1.70)和总生存期(HR 1.76)缩短显著相关。
  • 远处转移风险呈升高趋势但未达统计学显著(HR 1.67,95%CI 0.85–3.27)。

核心结论

  • 治疗前MRI显示的侧方淋巴结转移与局部复发率升高及无病生存期和总生存期缩短相关,提示仅依靠新辅助放化疗可能存在局限,并提示对部分患者可能需要强化治疗。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE和EMBASE数据库至2023年9月27日,纳入9项研究共3180例患者,采用QUIPS工具评价方法学质量,基于随机效应模型合并风险比(HR)和比值比(OR)。

诊断标准与关键数值

  • 治疗前MRI显示侧方淋巴结转移与局部复发相关(HR 4.11,95%CI 1.87–9.02)、与无病生存相关(HR 1.70,95%CI 1.42–2.03)、与总生存相关(HR 1.76,95%CI 1.44–2.15)、与远处转移相关(HR 1.67,95%CI 0.85–3.27,未达统计学显著)。

临床应用与阅片要点

  • 原文结论指出侧方淋巴结转移与局部复发及生存不良相关,强调仅依赖新辅助放化疗可能存在局限,并提示对特定患者可能需要强化治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To systematically review and meta-analyze the prognostic significance of lateral lymph node metastasis (LLNM) on pretreatment MRI in patients with rectal cancer who undergo neoadjuvant chemoradiation followed by curative surgical resection without lateral lymph node dissection (LLND).

METHODS: We searched the MEDLINE and EMBASE databases until September 27, 2023, utilizing the following search terms: (rectal OR rectum OR colorectal) AND (lateral OR sidewall) AND (lymph OR node). The QUIPS tool was employed to evaluate methodological quality. We pooled the association between LLNM on pretreatment MRI and outcomes such as local recurrence, distant metastasis, disease-free survival, and overall survival using hazard ratio (HR) and odds ratio (OR) based on random effects model.

RESULTS: We included 9 studies, encompassing 3180 patients. LLNM on pretreatment MRI revealed a significant association with increased local recurrence rates (HR: 4.11; 95 % CI: [1.87, 9.02]) and elevated risks for both disease-free (HR: 1.70; 95 % CI: [1.42, 2.03]) and overall survival (HR: 1.76; 95 % CI: [1.44, 2.15]). As for distant metastasis, our analysis indicated a potential trend towards increased rates, though this did not reach statistical significance (HR: 1.67; 95 % CI: [0.85, 3.27]).

CONCLUSIONS: Our findings underscore the relationship between LLNM and increased local recurrence and compromised disease-free and overall survival. This emphasizes the potential limitations of relying solely on neoadjuvant chemoradiation and highlights the potential need to intensify treatment in select patients.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Lee T, Horvat N, Gollub MJ, et al. Prognostic value of lateral lymph node metastasis in pretreatment MRI for rectal cancer in patients undergoing neoadjuvant chemoradiation followed by surgical resection without lateral lymph node dissection: A systemic review and meta-analysis. Eur J Radiol. 2024. PMID: 38972182. doi:10.1016/j.ejrad.2024.111601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。